Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors [Phase 1, Phase 2]
A Phase 1/2 study of RAS(ON) inhibitors in combination with Ivonescimab is currently recruiting in patients with solid tumors, including non…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Multimodal Nutritional and Sarcopenia Assessment for Risk Stratification in Lung Cancer Surgery
A clinical trial from Ondokuz Mayıs University is evaluating multimodal nutritional assessment and sarcopenia for risk stratification in pat…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Crizotinib Continuation Clinical Study [Phase 4]
A Phase 4 continuation study of crizotinib sponsored by Pfizer is currently active but not recruiting. The study investigates crizotinib in …
-
CLINICAL_TRIALS trial_result · 2026-03-30Clinical Trial Update: Expanded Access to Provide Sevabertinib (BAY 2927088) for the Treatment of Locally Advanced or Metastatic NSCLC With HER2 Mutation
Bayer is offering expanded access to Sevabertinib (BAY 2927088) for patients with locally advanced or metastatic non-small cell lung cancer …
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Safety of RAD301 in Healthy Human Volunteers and Patients With Pancreatic Cancer or Other Solid Tumors [Phase 1]
Phase 1 trial update on the safety of RAD301 in healthy volunteers and patients with pancreatic ductal adenocarcinoma or other solid tumors;…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Psilocybin-Assisted Therapy for the Treatment of Major Depressive Disorder in Patients With Non-Small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial evaluating psilocybin-assisted therapy for major depressive disorder in patients with non-small cell lung cancer. The…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Evaluation of JSKN016 Combination Therapy in Subjects With NSCLC [Phase 1]
Phase 1 clinical trial evaluating JSKN016 in combination therapy for advanced non-small cell lung cancer; the study is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Phase 2 Study of Fingolimod in Lung Cancers [Phase 2]
Phase 2 clinical trial evaluating Fingolimod in non-small cell lung cancer and small-cell lung cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue [NA]
A Memorial Sloan Kettering Cancer Center trial evaluating radiation therapy for solid tumors that have metastasized to soft tissue. The stud…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: A Platform Study in Non-Small Cell Lung Cancer (NSCLC) [Phase 1, Phase 2]
A platform trial in advanced or metastatic non-small cell lung cancer is currently recruiting for Phase 1 and Phase 2 cohorts sponsored by A…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: A Study to Assess a PI3Kδ Inhibitor (IOA-244) in Patients With Metastatic Cancers [Phase 1]
Phase 1 trial update for IOA-244, a PI3Kδ inhibitor, being studied in metastatic cancers with status currently ACTIVE_NOT_RECRUITING.
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: NIS to Examine the Effectiveness of TDC in Patients With Metastatic Non-squamous NSCLC and High-risk Genetic Alterations
This clinical trial update describes a non-interventional study to evaluate the effectiveness of TDC in patients with metastatic non-small c…
-
CLINICAL_TRIALS other · 2026-03-30Clinical Trial Update: WSD0922-FU for the Treatment of Glioblastoma, Anaplastic Astrocytoma, or Non-small Cell Lung Cancer With Central Nervous System Metastases [Phase 1]
Phase 1 clinical trial update for WSD0922-FU evaluating safety and preliminary activity in glioblastoma, anaplastic astrocytoma, and non-sma…
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: Study of Capmatinib in Chinese Adult Patients With Advanced Non-small Cell Lung Cancer Harboring MET Exon 14 Skipping Mutation [Phase 2]
A Phase 2 study of capmatinib in Chinese adults with advanced MET exon 14 skipping mutation–positive non-small cell lung cancer has complete…
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: Trial of Two Adagrasib Dosing Regimens in NSCLC With KRAS G12C Mutation (KRYSTAL 21) [Phase 2]
Phase 2 trial KRYSTAL 21 is evaluating two adagrasib dosing regimens in non-small cell lung cancer with KRAS G12C mutation; the study is act…
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid Tumors [Phase 1]
Phase 1 trial evaluating Nanrilkefusp alfa alone and with pembrolizumab in adults with advanced or metastatic solid tumors; the study (NCT04…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Phase 1B Trial of Intratumoral Cisplatin for Stage IV Lung Cancer [Phase 1]
Phase 1B trial of intratumoral cisplatin for stage IV non-small cell lung cancer is not yet recruiting. It represents early-phase exploratio…
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: Light Dosimetry for Photodynamic Therapy With Porfimer Sodium in Treating Participants With Malignant Mesothelioma or Non-Small Cell Lung Cancer With Pleural Disease Undergoing Surgery [Phase 1]
A Phase 1 trial update describes light dosimetry for photodynamic therapy using porfimer sodium in participants with malignant mesothelioma …
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: A Study to Evaluate the Tolerability, Safety, and PK of AST-201 in Patients With GPC3-positive Advanced Solid Tumors [Phase 1]
A Phase 1 study is evaluating tolerability, safety, and pharmacokinetics of AST-201 in patients with GPC3-positive advanced solid tumors; th…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: 177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors [Phase 1, Phase 2]
This clinical trial update describes ongoing Phase 1/2 studies of the radiopharmaceutical 177Lu-BetaBart. The trial is evaluating its use in…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: A Study of Targeted Radiation Therapy in People With Non-Small Cell Lung Cancer (NSCLC) [Phase 2]
A Phase 2 clinical trial is evaluating targeted radiation therapy for non-small cell lung cancer and is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Safety and Efficacy of OBX-115 in Advanced Solid Tumors [Phase 1, Phase 2]
A clinical trial update indicates OBX-115 is being studied in advanced solid tumors in Phase 1 and Phase 2, with recruitment ongoing for ind…
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: Osimertinib Combined With Intracranial SRT for EGFR-Mutant NSCLC With Symptomatic Brain Metastases
An ongoing clinical trial is evaluating osimertinib in combination with intracranial stereotactic radiotherapy for EGFR-mutant non-small cel…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: The Transitions Project: Supporting Adults During the Shift From Cancer Treatment to Surveillance [NA]
Massachusetts General Hospital reports an update on the Transitions Project, a study to support adults moving from cancer treatment to surve…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors [Phase 1]
Phase 1 trial evaluating HWK-007, a PTK7-directed antibody-drug conjugate, for advanced solid tumors; the study is currently recruiting.